Form 8-K - Current report:
SEC Accession No. 0001558370-25-002978
Filing Date
2025-03-14
Accepted
2025-03-14 11:47:13
Documents
19
Period of Report
2025-03-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K dwtx-20250312x8k.htm   iXBRL 8-K 55930
2 EX-5.1 dwtx-20250312xex5d1.htm EX-5.1 18769
3 EX-10.1 dwtx-20250312xex10d1.htm EX-10.1 233519
4 EX-99.1 dwtx-20250312xex99d1.htm EX-99.1 15161
5 GRAPHIC dwtx-20250312xex5d1001.jpg GRAPHIC 3774
6 GRAPHIC dwtx-20250312xex5d1004.jpg GRAPHIC 5440
7 GRAPHIC dwtx-20250312xex99d1002.jpg GRAPHIC 4807
  Complete submission text file 0001558370-25-002978.txt   530137

Data Files

Seq Description Document Type Size
8 EX-101.SCH dwtx-20250312.xsd EX-101.SCH 3398
9 EX-101.LAB dwtx-20250312_lab.xml EX-101.LAB 15928
10 EX-101.PRE dwtx-20250312_pre.xml EX-101.PRE 10043
21 EXTRACTED XBRL INSTANCE DOCUMENT dwtx-20250312x8k_htm.xml XML 4852
Mailing Address 44 MILTON AVENUE ALPHARETTA GA 30009
Business Address 44 MILTON AVENUE ALPHARETTA GA 30009 8666208655
Dogwood Therapeutics, Inc. (Filer) CIK: 0001818844 (see all company filings)

EIN.: 854314201 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39811 | Film No.: 25738480
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)